Molecular mechanism of transforming growth factor β-mediated cell-cycle modulation in primary human CD34+ progenitors

Blood

Volumn 99, Issue 2, 2002, Pages 499-506

  Dao, Mo A ^a,b   Hwa, Joseph ^a,b   Nolta, Jan A ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; NEUTRALIZING ANTIBODY; PROTEIN P15; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL CULTURE; CELL CYCLE; CELL LEVEL; COLONY FORMING CELL; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE COUNT; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; T LYMPHOCYTE; XENOTRANSPLANTATION;

EID: 0037079726     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.499     Document Type: Article

References (47)

1. TGF-beta signal transduction
2. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest
3. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
4. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1 Lu cells
5. Functional association of TGF-beta receptor II with cyclin B
6. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells
7. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
8. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures, I: Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta
9. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation
10. + hematopoietic progenitor cells
11. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes
12. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells
13. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit
14. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice
15. Stem cell engraftment and cell cycle phenotype
16. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population
17. - cells with both lymphoid and myeloid potential
18. - human hematopoietic progenitors assessed in immune-deficient mice
19. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors
20. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations
21. D-type cyclin-dependent kinase activity in mammalian cells
22. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
23. Molecular control of cell cycle progression in primary human hematopoietic stem cells: Methods to increase levels of retroviral-mediated transduction
24. Expression of G1-phase cell cycle genes during hematopoietic lineage
25. Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb
26. The nonobese diabetic scid mouse: Model for spontaneous thymomagenesis associated with immunodeficiency
27. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice
28. Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model
29. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
30. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells
31. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent
32. + human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus
33. Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells
34. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: Effects of mast cell growth factor (MGF) combined with other cytokines
35. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells
36. + cells from patients with Gaucher disease: In vivo detection of transduced cells without myeloablation
37. Gene therapy for hematopoietic and immune disorders
38. + cells in ADA-deficient SCID neonates
39. Gene therapy for adenosine deaminase deficiency
40. Retroviral-mediated gene transduction of c-kit into single hematopoietic progenitor cells from cord blood enhances erythroid colony formation and decreases sensitivity to inhibition by tumor necrosis factor-alpha and transforming growth factor-beta1
41. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer
42. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay
43. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency
44. Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-beta but not macrophage inflammatory protein-1 alpha activities
45. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0)
46. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0/G1 phase of the cell cycle
47. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice